Anhedonia and neuropsychotropics: a pharmacovigilance-pharmacodynamic study

THERAPIE · Published 2026-07-01 · DOI 10.1016/j.therap.2026.07.003

Authors (1)

Jean-Louis Montastruc

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Montastruc, J. (2026). Anhedonia and neuropsychotropics: a pharmacovigilance-pharmacodynamic study. THERAPIE. https://doi.org/10.1016/j.therap.2026.07.003

Related articles

• Acute pancreatitis followed by leukocytoclastic vasculitis induced by tirzepatide: a first case report with this new medication* · THERAPIE · 2026 · Same journal
• Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France · THERAPIE · 2026 · Same journal
• Céphalées persistantes secondaires à une injection de dalbavancine : à propos d’un cas · THERAPIE · 2026 · Same journal
• Comment discriminer les médicaments d’ASMR V : quelles implications et quel parcours d’accès ? · THERAPIE · 2025 · Same journal
• How can the level of health product education (literacy) be raised among the general public? · THERAPIE · 2025 · Same journal
• Descriptive study of the effects of treprostinil and/or epoprostenol in newborn infants with inhaled NO refractory persistent pulmonary hypertension of the newborn (PPHN) · THERAPIE · 2026 · Same journal
• L’automédication et ses déterminants parmi les militaires français en mission sur les bâtiments de surface de la Marine nationale : une étude descriptive · THERAPIE · 2026 · Same journal
• Angioedema reported with tissue plasminogen activators: A need to communicate on bradykinin- and histamine-mediated mechanisms · THERAPIE · 2026 · Same journal
• Antipsychotics switching, a specific risk of thromboembolic events? A case report · THERAPIE · 2026 · Same journal
• Artificial intelligence for precision medicine · THERAPIE · 2025 · Same journal